The USMIRC is a powerful conglomerate comprising several hospital and academic centers, alongside their dedicated healthcare teams. These institutions are at the forefront of researching and developing new therapies for multiple myeloma, other plasma cell disorders, and collaborating with leading groups in the fields of lymphoma and leukemia. Their unwavering commitment is to significantly enhance outcomes for patients suffering from these disorders.

The goal of the USMIRC extends beyond research and improved therapy to encompass mentoring and educating researchers and healthcare workers. If you are keen on the groundbreaking work being carried out by the USMIRC, we encourage you to reach out to us through the contact form on our page.